Biotech

All Articles

Bicara, Zenas find IPOs to push late-phase possessions toward market

.Bicara Rehabs and Zenas Biopharma have actually delivered new inspiration to the IPO market along w...

Genentech to close cancer cells immunology study division

.Genentech will close its own cancer cells immunology study team, and also unit head and also well-k...

Kezar drops solid cyst but to prove its really worth in period 1 test

.Kezar Life Sciences is dropping its own dim phase 1 strong tumor medicine as the biotech goes all-i...

Acelyrin loses izokibep, drops 3rd of workers

.In spite of izokibep preserving its own newly found winning touch in the center, Acelyrin is no mor...

Rivus' stage 2 obesity-related heart failure test attacks endpoint

.Rivus Pharmaceuticals has plumped up the leads of its fat-busting, muscle-sparing drug applicant, d...

Ovid stops preclinical job, IV program after soticlestat stop working

.Ovid Therapy currently revealed final month that it was trimming its headcount as the business gets...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Seaport

.Eli Lilly has actually opened up a $700 thousand R&ampD center in the Boston ma Seaport, enhancing ...

Boundless Biography makes 'reasonable' discharges five months after $100M IPO

.Merely 5 months after protecting a $100 thousand IPO, Vast Biography is actually already giving up ...

Halda's $126M is going to progress 'secure and get rid of' growth drugs

.The initial stages of oncology R&ampD may not be except interesting new modalities, as well as Hald...

Lykos 'regrets' not revealing research violations with author

.Psychopharmacology has actually taken 3 posts regarding midstage medical trial information examinin...